Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy Participants
Clinical trial NCT05428696 · COMPLETED
Trial details
- NCT number
- NCT05428696
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-12
- Primary completion
- 2023-04-24
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.